Gacyclidine: Beaufour-Ipsen

Current Opinion in Investigational Drugs

Volumn 2, Issue 6, 2001, Pages 814-819

  Mitha, A P A ^a   Maynard, K I ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIZOCILPINE; GACYCLIDINE; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; ORGANOPHOSPHORUS COMPOUND; PLACEBO; SOMAN; THIENYLCYCLOHEXYLPIPERIDINE; UNCLASSIFIED DRUG;

ACUTE DISEASE; AREA UNDER THE CURVE; ATAXIA; BINDING AFFINITY; BINDING COMPETITION; BOLUS INJECTION; BRAIN INJURY; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CHEMICAL MODIFICATION; CLINICAL TRIAL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; DRUG INFUSION; DRUG METABOLISM; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG SCREENING; DRUG SYNTHESIS; ENANTIOMER; GAS POISONING; HUMAN; IC 50; LEARNING DISORDER; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PHASE 2 CLINICAL TRIAL; PROTEIN EXPRESSION; RACEMIC MIXTURE; REACTION ANALYSIS; REVIEW; SPINAL CORD INJURY; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION; VISUAL DISORDER;

ANIMALS; CLINICAL TRIALS; CYCLOHEXANES; CYCLOHEXENES; HUMANS; NEUROPROTECTIVE AGENTS; PIPERIDINES; RECEPTORS, N-METHYL-D-ASPARTATE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034790001     PISSN: 09678298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Gacyclidine: A potent neuroprotective agent in rat spinal cord injury
2. Gacyclidine: A new NMDA antagonist. Binding properties to the rat central nervous system
3. Brain '99/BrainPET '99; 19th International Symposium on Cerebral Blood Flow and Metabolism and the Fourth International Conference on Quantification of Brain Function with PET, Copenhagen, Denmark
4. Society for Neuroscience 29th Annual Meeting (Part IV) Miami Beach, FL, USA
5. Acute spinal cord injury: Early care and treatment in a multicenter study with Gacyclidine
6. Effects of Gacyclidine, a non-competitive NMDA receptor antagonist, in human healthy volunteers
7. Binding of gacyclidine, a potent neuroprotector, in the rat central nervous system
8. Localization of gacyclidine non-NMDA binding sites in the cerebellum of mutant mice: An autoradiographic study
9. ProTec: A dose-effect study of gacyclidine in patients with severe traumatic brain injury
10. Drug development pipeline: Gacyclidine
11. Society for Neuroscience 29th Annual Meeting (Part XI), Miami Beach, FL, USA
12. FENS2000 - Federation of European Neuroscience Societies (Part III), Brighton, UK
13. Excitotoxicity in acute and chronic neurodegeneration
14. Drug development pipeline - Gacyclidine
15. Distribution of gacyclidine enantiomers in spinal cord extracellular fluid
16. The novel non-competitive N-methyl-D-aspartate antagonist gacyclidine blocks the glutamate-induced release of hydroxyl radicals in the striatum under conditions in which dizocilpine does not. A microdialysis study in rats
17. Neuroprotective effects of gacyclidine after experimental photochemical spinal cord lesion in adult rats: Dose-window and time-window effects
18. In vitro neuroprotection against glutamate toxicity provided by novel non-competitive N-methyl-D-aspartate antagonists
19. Review of the value of gacyclidine (GK-11) as adjuvant medication to conventional treatments of organophosphate poisoning: Primate experiments mimicking various scenarios of military or terrorist attack by soman
20. Promising additional neuroprotective therapy for organophosphate poisoning
21. Morphological and morphometric analysis of serotonin-containing neurons in primary dissociated cultures of human rhombencephalon: A study of development
22. Determination of gacyclidine enantiomers in human plasma by gas chromatography-mass spectrometry using selected-ion monitoring
23. Neuroprotective effect of N-methyl-D-aspartate non-competitive antagonists (arylcyclohexylamine derivatives) on human cultured spinal cord cells
24. Neuroprotective effects of a novel NMDA antagonist, gacyclidine, after experimental contusive spinal cord injury in adult rats
25. GFAP mRNA expression after diffuse axonal injury (DAI) in rat brain: Effect of an antagonist of NMDA receptor, GK-11
26. In vitro neuroprotection by non-competitive NMDA antagonists
27. Primary dissociated cultures of human brainstem cells: A useful tool for their characterization and neuroprotection study
28. Effect of three non competitive inhibitors of the NMDA receptor in two models of rodents intoxication by soman
29. Determination conformationnelle de derives de la phencyclidine en vue d'une correlation structure-activite
30. TCP enhances the survival of human fetal spinal cord cells in culture
31. Homochiral structures derived from 1-[1-(2-thienyl)cyclohexyl]piperidine (TCP) are potent non-competitive antagonists of glutamate at NMDA receptor sites
32. Effects of the novel NMDA receptor antagonist gacyclidine on recovery from medial frontal cortex contusion injury in rats
33. MK-801 neurotoxicity in male mice: Histological effects and chronic impairment in spatial learning
34. Drug development - Gacyclidine